48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine.

MLA

Azar, Pouya, et al. “48-Hour Induction of Transdermal Buprenorphine to Extended-Release Buprenorphine.” Journal of Addiction Medicine, vol. 18, no. 1, Jan. 2024, pp. 82–85. EBSCOhost, https://doi.org/10.1097/ADM.0000000000001231.

APA

Azar, P., Wong, J. S. H., Mathew, N., Ignaszewski, M. J., Partovi, N., Krausz, R. M., Ajidahun, A., Thotakura, S., Harris, M., Barrios, R., Montaner, J. S. G., & Maharaj, A. R. (2024). 48-hour Induction of Transdermal Buprenorphine to Extended-release Buprenorphine. Journal of Addiction Medicine, 18(1), 82–85. https://doi.org/10.1097/ADM.0000000000001231

Chicago

Azar, Pouya, James S. H. Wong, Nickie Mathew, Martha J. Ignaszewski, Nilufar Partovi, Reinhard M. Krausz, Adedayo Ajidahun, et al. 2024. “48-Hour Induction of Transdermal Buprenorphine to Extended-Release Buprenorphine.” Journal of Addiction Medicine 18 (1): 82–85. doi:10.1097/ADM.0000000000001231.